Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +751 | +11.43% | $0.00 | 7.32K | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$90.4K | -268 | -3.66% | $337.32 | 7.06K | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +520 | +7.37% | $0.00 | 7.58K | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$73.5K | -218 | -2.88% | $337.32 | 7.36K | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +405 | +5.5% | $0.00 | 7.76K | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$48.9K | -145 | -1.87% | $337.32 | 7.62K | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +434 | +5.7% | $0.00 | 8.05K | Sep 2, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$52.3K | -155 | -1.92% | $337.32 | 7.9K | Sep 2, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +557 | +7.05% | $0.00 | 8.45K | Sep 3, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$94.6K | -283 | -3.35% | $334.31 | 8.17K | Sep 3, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -751 | -24.99% | $0.00 | 2.25K | Sep 1, 2024 | Bio-Rad A Common Stock | 751 | $0.00 | Direct | F2, F3 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -520 | -33.29% | $0.00 | 1.04K | Sep 1, 2024 | Bio-Rad A Common Stock | 520 | $0.00 | Direct | F2, F4 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -405 | -49.94% | $0.00 | 406 | Sep 1, 2024 | Bio-Rad A Common Stock | 405 | $0.00 | Direct | F2, F5 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -434 | -100% | $0.00 | 0 | Sep 2, 2024 | Bio-Rad A Common Stock | 434 | $0.00 | Direct | F2, F6 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -557 | -100% | $0.00 | 0 | Sep 3, 2024 | Bio-Rad A Common Stock | 557 | $0.00 | Direct | F2, F7 |
Id | Content |
---|---|
F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
F3 | On September 1, 2023, the reporting person was granted 3,005 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F4 | On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F5 | On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F6 | On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F7 | On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |